![Andrei Vladimirovich Petrov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrei Vladimirovich Petrov
Directeur Technique/Scientifique/R&D chez International Biotech Center Generium, LLC
Postes actifs de Andrei Vladimirovich Petrov
Sociétés | Poste | Début | Fin |
---|---|---|---|
International Biotech Center Generium, LLC
![]() International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | Directeur Technique/Scientifique/R&D | 01/01/2011 | - |
enGene, Inc.
![]() enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 01/01/2015 | - |
Historique de carrière de Andrei Vladimirovich Petrov
Anciens postes connus de Andrei Vladimirovich Petrov
Sociétés | Poste | Début | Fin |
---|---|---|---|
Avelas Biosciences, Inc.
![]() Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Directeur/Membre du Conseil | - | 14/03/2017 |
ARGOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2013 | 13/12/2016 |
Independent Dir/Board Member | 01/08/2013 | 13/12/2016 | |
CO.DON AG | Directeur/Membre du Conseil | 17/09/2012 | 20/07/2015 |
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | - | - |
Formation de Andrei Vladimirovich Petrov
Moscow State University Lomonosov | Undergraduate Degree |
Statistiques
Internationale
Russie | 3 |
Etats-Unis | 3 |
Danemark | 2 |
Opérationnelle
Director/Board Member | 5 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 4 |
Health Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CO.DON AG | Health Services |
Entreprise privées | 5 |
---|---|
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
International Biotech Center Generium, LLC
![]() International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | Commercial Services |
Argos Therapeutics, Inc.
![]() Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
enGene, Inc.
![]() enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
Avelas Biosciences, Inc.
![]() Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |